Oasmia Pharmaceutical Ab Asset Turnover Ratio (OASM), as of fourth quarter 2018, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Oasmia Pharmaceutical Ab  (OASM)
 

Oasmia Pharmaceutical Ab Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Oasmia Pharmaceutical Ab asset turnover ratio, the ability of Oasmia Pharmaceutical Ab's assets to generate revenue in the fourth quarter 2018, increased sequentially to 0.01 in the fourth quarter (Apr 30 2018), a new company high.

Within sector 212 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2018 compared to the preceding quarter from 0 to 4343.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OASM Asset Turnover Ratio (Apr 30 2018)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Asset Change - - - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.01 - - - -
OASM's Total Ranking # 4343 # 0 # 0 # 0 #
Seq. Asset Change 0 % 0 % 0 % - -
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 213
Healthcare Sector # 532
Overall Market # 4343

Asset Turnover Ratio Statistics
High Average Low
0.01 0.01 0.01
(Apr 30 2018)  




OASM Company Profile • Back to OASM Efficiency Comparisons • Compare OASM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Apr 30 2018, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Apr 30 2018 Assets at quarter ending Apr 30 2018
Ibio inc   0.01 $ 0.500  Millions$ 34.122  Millions
Imunon Inc   0.01 $ 0.500  Millions$ 36.792  Millions
Checkpoint Therapeutics inc   0.01 $ 0.343  Millions$ 28.111  Millions
Gyre Therapeutics Inc   0.01 $ 0.753  Millions$ 64.856  Millions
Immunomedics Inc   0.01 $ 2.412  Millions$ 212.944  Millions
Matinas Biopharma Holdings Inc   0.01 $ 0.165  Millions$ 15.059  Millions
Cogent Biosciences Inc   0.01 $ 2.220  Millions$ 206.808  Millions
Timber Pharmaceuticals Inc   0.01 $ 0.072  Millions$ 6.803  Millions
Sophiris Bio Inc.  0.01 $ 0.274  Millions$ 26.180  Millions
Theravance Biopharma inc   0.01 $ 4.630  Millions$ 498.927  Millions
Abeona Therapeutics Inc   0.01 $ 1.182  Millions$ 136.702  Millions
Otonomy Inc   0.01 $ 1.179  Millions$ 138.631  Millions
Rafael Holdings Inc  0.01 $ 1.093  Millions$ 130.952  Millions
Northwest Biotherapeutics Inc  0.01 $ 0.400  Millions$ 48.954  Millions
Aceragen Inc   0.01 $ 0.779  Millions$ 96.073  Millions
Vbi Vaccines Inc  0.01 $ 0.916  Millions$ 115.238  Millions
Anavex Life Sciences Corp   0.01 $ 0.210  Millions$ 26.620  Millions
Adverum Biotechnologies Inc   0.01 $ 1.603  Millions$ 216.463  Millions
Pulse Biosciences Inc   0.01 $ 0.303  Millions$ 44.173  Millions
Journey Medical Corp  0.01 $ 3.774  Millions$ 612.222  Millions
Oasmia Pharmaceutical Ab  0.01 $ 3.169  Millions$ 568.075  Millions
Vyne Therapeutics Inc   0.01 $ 0.497  Millions$ 95.506  Millions
Scynexis Inc 0.00 $ 0.257  Millions$ 53.198  Millions
Cellular Biomedicine Group Inc 0.00 $ 0.289  Millions$ 65.348  Millions
Tempest Therapeutics Inc 0.00 $ 0.299  Millions$ 77.948  Millions
Bellicum Pharmaceuticals Inc 0.00 $ 0.518  Millions$ 141.844  Millions
Cnbx Pharmaceuticals Inc 0.00 $ 0.008  Millions$ 3.471  Millions
Revance Therapeutics Inc 0.00 $ 0.380  Millions$ 234.185  Millions
Dynavax Technologies Corporation 0.00 $ 0.344  Millions$ 220.978  Millions
Tg Therapeutics Inc 0.00 $ 0.152  Millions$ 105.339  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.